The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
The Toxicologist - Society of Toxicology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
have now compared the IC50 values between human, dog, rat and mouse for<br />
Imatinib, Erlotinib, Dasatinib, Sorafenib and Sunitinib. Bone marrow cells from<br />
each <strong>of</strong> the species and KIs were mixed with ColonyGel methylcellulose-based<br />
media containing appropriate species-specific cytokines and plated in 35 mm<br />
dishes (n=3). CFU-GM were enumerated on days 7-14 (species dependent) and the<br />
IC50 values determined for each drug for each species. IC50 values determined<br />
using dog marrow compared well with human values (e.g.IC50 for Imatinib,<br />
Dasatinib and Sorafenib were 2.1, 0.01 and 2.3 μM for dog and 2.5, 0.008 and 3.5<br />
μM for human CFU-GM). In addition, the rank order <strong>of</strong> the 5 KIs was similar in<br />
dog and human assays. In contrast, the IC50 values for the same drugs in rat and<br />
mouse assays differed significantly (e.g. IC50 for Imatinib, Dasatinib and Sorafenib<br />
were 25, 0.32 and 42 μM for rat and 67, 0.9 and 120 μM for mouse CFU-GM)<br />
and the compounds did not rank in the same order. <strong>The</strong>se data suggest that rat and<br />
mouse derived IC50 values for KIs may not accurately reflect the relative toxicity <strong>of</strong><br />
newly designed molecules in this compound class.<br />
1173 DEVELOPMENT AND CHARACTERIZATION OF<br />
HUMAN HEPATOCYTES DERIVED FROM INDUCED<br />
PLURIPOTENT STEM CELLS (IPSC): A NOVEL IN<br />
VITRO MODEL SYSTEM FOR ASSESSING DRUG-<br />
INDUCED HEPATOTOXICITY.<br />
V. L. Ott, P. Fuhrken, J. Luebke-Wheeler, C. Kannemeier, B. Swanson, W.<br />
Wang and E. Nuwaysir. Cellular Dynamics International, Madison, WI. Sponsor:<br />
K. Kolaja.<br />
Hepatotoxicity and drug-induced liver injury (DILI) are the most common reasons<br />
for drug failure during development and market withdrawal <strong>of</strong> approved drugs.<br />
Liver diseases associated with drug toxicity can be attributed, in large part, to the<br />
lack <strong>of</strong> biologically relevant and predictive model systems. Current hepatocyte<br />
model systems include primary human hepatocytes (PHH) harvested from cadavers,<br />
immortalized cell lines and animal models. Each <strong>of</strong> these presents limitations<br />
in functionality, reproducibility and/or availability. Human hepatocytes derived<br />
from induced pluripotent stem cells (iPSCs), which are stem cells derived from<br />
adult tissue, <strong>of</strong>fer the potential to overcome these limitations. We have developed<br />
human iPSC-derived hepatocytes that are >95% pure and exhibit characteristic hepatocyte<br />
morphology, gene and protein expression (e.g. albumin, alpha-1-antitrypsin,<br />
ASGR1, HNF family transcription factors). Human iPSC-derived hepatocytes<br />
produce albumin protein at levels similar to PHH and ~7-fold greater than<br />
HepG2 cells. In addition, >50% <strong>of</strong> the cells store glycogen and lipid, as demonstrated<br />
by Periodic Acid Schiff and Oil Red staining, respectively. Human iPSC-derived<br />
hepatocytes express Phase I and II metabolic enzymes (e.g. CYP1A2, 2B6,<br />
2C8/9/19, 2D6, 3A4, UGT, ST and GST) at levels similar to PHH, and CYP3A4<br />
activity is induced ≥3-fold in response to dexamethasone and rifampicin. Finally,<br />
human iPSC-derived hepatocytes express key uptake and efflux transporters (e.g.<br />
MDR-1/P-gp, MRP2, BSEP, BCRP, NTCP and OATPs) and exhibit formation <strong>of</strong><br />
bile canaliculi. <strong>The</strong> development <strong>of</strong> human iPSC-derived hepatocotyes that recapitulate<br />
in vivo hepatocyte function will enable better predictivity <strong>of</strong> drug-induced<br />
hepatotoxicity during the earlier pre-clinical stages <strong>of</strong> drug development, more successful<br />
clinical trials, and the delivery <strong>of</strong> new drug therapieeis across a wide range <strong>of</strong><br />
diseases.<br />
1174 BIOLOGICAL SURFACE ADSORPTION INDEX (BSAI)<br />
FOR CHARACTERIZING CARBON NANOMATERIALS<br />
WITH DIFFERENT SURFACE CHEMISTRIES IN<br />
BIOLOGICAL SYSTEMS.<br />
X. Xia, N. A. Monteiro-Riviere and J. E. Riviere. Center for Chemical <strong>Toxicology</strong><br />
Research and Pharmacokinetics, North Carolina State University, Raleigh, NC.<br />
<strong>The</strong> behavior <strong>of</strong> nanomaterials in a biological or environmental system is governed<br />
by the molecular interactions <strong>of</strong> their surface species with the biological or environmental<br />
components. Quantitative assessment <strong>of</strong> the adsorption properties <strong>of</strong> nanomaterials<br />
is a crucial step for developing predictive structure-activity relationship in<br />
nanomedicine and risk assessment <strong>of</strong> nanomaterials. We have developed a biological<br />
surface adsorption index (BSAI) approach to characterize the surface activity <strong>of</strong><br />
nanomaterials in biological systems. A set <strong>of</strong> small molecules having diverse physicochemical<br />
properties was used as probe compounds. <strong>The</strong> adsorption coefficients (k)<br />
<strong>of</strong> the probe compounds were obtained by measuring the quantities <strong>of</strong> the probe<br />
compounds adsorbed on the surfaces <strong>of</strong> the nanomaterials and the equilibrium concentrations<br />
<strong>of</strong> the probe compounds in the media. <strong>The</strong> log (k) values were scaled to<br />
a set <strong>of</strong> solvation molecular descriptors <strong>of</strong> the probe compounds via multiple linear<br />
regressions to provide a set <strong>of</strong> five nano-descriptors representing the contributions<br />
<strong>of</strong> the five types <strong>of</strong> molecular interactions (hydrophobicity, hydrogen-bond acidity<br />
and basicity, dipolarity/polarizability, and lone pair electrons). <strong>The</strong> nano-descriptors<br />
for multi-walled carbon nanomaterials (MWCNT) with different surface<br />
chemistries (unmodified, -OH and –COOH modified) and fullerenes were measured;<br />
for example, the regression model obtained for MWCNT (-OH modified)<br />
was log(k) = 0.77R + 2.55π - 0.14α - 2.36β + 4.90V; n=30, R 2 =0.89. <strong>The</strong> measured<br />
nano-descriptors can be used to develop predictive structure-activity relationships<br />
in nanomedicine and nanomaterial risk assessments. (Supported by US EPA<br />
STAR Grant# R833328 and NIH R01 ES016138)<br />
1175 CELLULAR UPTAKE MECHANISMS AND<br />
CYTOTOXICITY OF QUANTUM DOT NANOPARTICLES<br />
IN PORCINE DENDRITIC CELLS.<br />
L. W. Zhang and N. A. Monteiro-Riviere. Center for Chemical <strong>Toxicology</strong> Research<br />
and Pharmacokinetics, North Carolina State University, Raleigh, NC.<br />
Quantum dots (QD) serve as excellent fluorescent probes and are novel tools used<br />
in biomedical applications but the toxicity and mechanism <strong>of</strong> cellular uptake are<br />
poorly understood. Peripheral blood mononuclear cells were isolated from porcine<br />
blood by gradient centrifugation and monocytes were purified with anti-CD14 antibody<br />
conjugated beads. Monocytes dosed with 0.05nM <strong>of</strong> QD655 coated with<br />
carboxylic acid (QD655-COOH, 18nm) for 30min showed cellular uptake while<br />
lymphocytes did not take up QD655-COOH. Monocytes were differentiated into<br />
dendritic cells (DC) with granulocyte-macrophage colony stimulating factor and<br />
IL-4. Cellular uptake <strong>of</strong> DC increased six-fold compared to monocytes when cells<br />
were dosed with 2nM <strong>of</strong> QD655-COOH for 30min. QD655 coated with polyethylene<br />
glycol (PEG) (45nm) or QD655 PEG-amine (20nm) did not show endocytic<br />
uptake in monocytes or DC. QD655-COOH uptake in DC was saturated at 4-6h<br />
and TEM showed QD in the cytoplasmic vacuoles <strong>of</strong> DC. Twelve endocytic inhibitors<br />
were used to investigate the cellular uptake mechanisms <strong>of</strong> QD655-<br />
COOH in DC. <strong>The</strong>se results showed that cytochalasin D and chlorpromazine inhibited<br />
QD uptake by 50%, demonstrating that cytoskeleton F-actin and clathrin<br />
regulated the QD655-COOH endocytosis <strong>of</strong> DC. <strong>The</strong> cellular uptake was primarily<br />
regulated by scavenger receptor and phospholipase C. Scavenger receptor and a<br />
phospholipase c (U-73122) inhibitors blocked QD uptake. In addition, DC maturation<br />
with lipopolysaccharide (LPS) caused an increase in QD655-COOH uptake<br />
compared to DC without LPS. Viability assays including 96AQ, CCK-8,<br />
alamarBlue and ApoTox exhibited minimal toxicity in DC dosed with QD655-<br />
COOH at 24h. However, glutathione levels showed a significant decrease with<br />
10nM <strong>of</strong> QD655-COOH. Lastly, QD655-COOH not only suppressed<br />
CD80/CD86 expression on the surface <strong>of</strong> DC but decreased LPS induced<br />
CD80/CD86 expression. <strong>The</strong>se findings shed light on the cytotoxicity and mechanisms<br />
<strong>of</strong> QD cellular uptake in DC.<br />
1176 EVALUATION OF TOXICITY AND INFLAMMATION IN<br />
THREE DIFFERENT HYDROXYLATED FULLERENES<br />
(C 60 (OH) X ) IN HUMAN CELLS.<br />
J. G. Saath<strong>of</strong>f 1 , X. Xia 1 , J. E. Riviere 1 , A. O. Inman 1 , A. R. Badireddy 2 , M. R.<br />
Wiesner 2 and N. A. Monteiro-Riviere 1 . 1 Center for Chemical <strong>Toxicology</strong> Research<br />
and Pharmacokinetics, North Carolina State University, Raleigh, NC and 2 Civil and<br />
Environmental Engineering, Duke University, Durham, NC.<br />
Carbon fullerenes (C 60 ) possess unique chemical properties and their interactions<br />
with biomolecules have widespread applications in biomedical technologies.<br />
Functionalization <strong>of</strong> C 60 with hydroxyl groups can increase the solubility and potential<br />
for cellular interaction. <strong>The</strong>re is much speculation as to the potential benefits<br />
<strong>of</strong> the medical application <strong>of</strong> solubilized fullerenes (i.e. MRI contrast agents,<br />
target drug delivery, etc.), and although industrial use and production continues to<br />
increase the health and safety effects <strong>of</strong> hydroxylated C 60 within biological systems<br />
is poorly understood. Conflicting reports regarding the cytotoxicity and inflammation<br />
<strong>of</strong> functionalized C 60 exists. Hydroxylated fullerenes (C 60 (OH) x ) were synthesized<br />
using the prepared phase transfer method. In an attempt to further elucidate<br />
the potential for toxicity <strong>of</strong> functionalized C 60 , human epidermal keratinocytes<br />
(HEK) were exposed to three different hydroxylated fullerenes. C 60 (OH) 20 ,<br />
C 60 (OH) 24 , and C 60 (OH) 32 at concentrations ranging from 0.000544 to<br />
42.5μg/ml for 24 and 48hr (n=12 wells/treatment) were exposed to HEK, and<br />
alamarBlue (aB) viability assay and IL-8 cytokine analysis were conducted. A statistically<br />
significant (p